361 related articles for article (PubMed ID: 3476692)
1. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer].
Yukawa H; Kono N; Taniguchi K; Ieda K; Ono K; Yamamoto S; Koh K; Ohta M; Hayashido M; Yamaguchi K
Nihon Geka Hokan; 1984 Mar; 53(2):433-6. PubMed ID: 6508467
[No Abstract] [Full Text] [Related]
3. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
[TBL] [Abstract][Full Text] [Related]
4. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
6. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of tumor markers in patients with colorectal cancer].
Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
[TBL] [Abstract][Full Text] [Related]
10. [Clinical utility of tumor markers in gastric and colon cancer].
Ogawa K; Naritaka Y; Koyama N; Ohtani Y; Kawata H; Yagawa H; Kajiwara T; Sakakibara N
Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. I. Prediction of tumour stage.
Ståhle E; Glimelius B; Bergström R; Påhlman L
Eur J Surg Oncol; 1988 Aug; 14(4):277-86. PubMed ID: 3165869
[TBL] [Abstract][Full Text] [Related]
12. [Preoperative determination of carcinoembryonic antigen and gastrointestinal antigen in neoplastic colorectal pathology. Case contributions].
Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
Minerva Chir; 1987 Jun; 42(12):1037-43. PubMed ID: 3476864
[No Abstract] [Full Text] [Related]
13. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. II. Prediction of prognosis.
Ståhle E; Glimelius B; Bergström R; Påhlman L
Eur J Surg Oncol; 1988 Aug; 14(4):287-96. PubMed ID: 3165870
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
Sekikawa K
Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
[No Abstract] [Full Text] [Related]
15. [Preliminary results of the clinical use of TPA (tissue polypeptide antigen)].
Dalla Pria AF; Guolo P; Piaserico PL; Ricci G; Berlanda G; Gobbi V; Minello S
Arch De Vecchi Anat Patol; 1983 Jul; 65(2-3):301-13. PubMed ID: 6680294
[No Abstract] [Full Text] [Related]
16. Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma.
Putzki H; Student A; Jablonski M; Heymann H
Cancer; 1987 Jan; 59(2):223-6. PubMed ID: 3467817
[TBL] [Abstract][Full Text] [Related]
17. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S
Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
[TBL] [Abstract][Full Text] [Related]
18. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
19. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
[No Abstract] [Full Text] [Related]
20. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
